StockData
AgomAb Therapeutics NV logo

AgomAb Therapeutics NV (AGMB) KPIs and segments

AGMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 23, 2026Score 2/30
$5.97−0.39 (-6.13%)

Close on Nov 16, 2026Market cap $149.25KP/E –Yield –

KPIs & segments

Operating metrics and segments that drive AgomAb Therapeutics's business

Coming soon

This tab will track the numbers specific to AgomAb Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?